Surgery plus chondroprotection for canine cranial cruciate ligament (CCL) rupture

A. Crovace; L. Lacitignola; A. Miolo; F. P. Fanizzi

doi:10.1055/s-0038-1633007

Veterinary and Comparative Orthopaedics and Traumatology, Inhaltsverzeichnis

Vet Comp Orthop Traumatol 2006; 19(04): 239-245
DOI: 10.1055/s-0038-1633007

Clinical Communication

Schattauer GmbH

Surgery plus chondroprotection for canine cranial cruciate ligament (CCL) rupture

A proton-NMR study

A. Crovace

¹Emergency and Organ Transplantation Department (D.E.T.O.), Veterinary Surgery Division, University of Bari, Valenzano, Italy

,

L. Lacitignola

²Faculty of Veterinary Medicine, Department of Veterinary Clinical Sciences, University of Teramo, Italy

,

A. Miolo

³Scientific Documentation and Information Centre (CeDIS), Innovet Italia srl, Rubano, Italy

,

F. P. Fanizzi

⁴Dipartimento di Scienze e Tecnologie Biologiche ed Ambientali, Università di Lecce, Lecce, Italy

⁵Consortium C.A.R.S.O. Cancer Research Center, Bari, Italy

› Institutsangaben

Abstract

Summary

Rupture of the cranial cruciate ligament (CCL) is one of the most frequent causes of lameness of the rear limb in the dog. Regardless of the type of treatment, CCL rupture inevitably leads to knee osteoarthritis (OA). The purpose of this study was to evaluate the efficacy of associating surgical treatment of spontaneous rupture of the CCL with a chondroprotector, that is called “supraadditive” because it is formulated to counteract not only chondrodegeneration, but also the oxidative and inflammatory processes of OA. The open-label controlled study used proton NMR spectroscopy to evaluate the synovial fluid of the stifle of 10 dogs with monolateral rupture of the CCL, selected for the study based on specific inclusive criteria. The dogs were assigned randomly into two groups. Five dogs received the supra-additive chondroprotector for 60 days, starting on the day after surgery. Five dogs only underwent surgical reconstruction of the CCL. The results were analysed with the ANOVA unstructured variance matrix-covariance test. The trend overtime of the synovial concentration of four metabolites (lactate, alanine, acetyl groups of N-acety-lated sugars on glycoproteins and alpha-anomers of glucose) was found to differ to a statistically significant extent between the two groups, suggesting that the supra-additive chondroprotector produces an intra-ar-ticular metabolic rebalance. The results support the adjuvant use of the chondroprotector in the management of CCL rupture, in view of its control of the OA changes that accompany this orthopaedic disabling condition.

Keywords

Osteoarthritis - dogs - cranial cruciate ligament - chondroprotection - spectroscopy

Volltext

Referenzen

References
1 Comerford EJ, Tarlton JF, Innes JF. et al. Metabolism and composition of the canine anterior cruciate ligament relate to differences in knee joint mechanics and predisposition to ligament rupture. J Orthop Res 2005; 23: 61-6.
2 Duval JM, Budsberg SC, Flo GL. et al. Breed, sex, and body weight as risk factors for rupture of the cranial cruciate ligament in young dogs. J Am Vet Med Assoc 1999; 215: 811-4.
3 Lampman TJ, Lund EM, Lipowitz AJ. Cranial cruciate disease: current status of diagnosis, surgery and risk for disease. Vet Comp Orthop Traumatol 2003; 16: 122-6.
4 Selmi AL, PadilhaFilho JG. Rupture of the cranial cruciate ligament associated with deformity of the proximal tibia in five dogs. J Small Anim Pract 2001; 42: 390-3.
5 Whitehair JG, Vasseur PB, Willits NH. Epidemiology of cranial cruciate ligament rupture in dogs. J Am Vet Med Assoc 1993; 203: 1016-9.
6 Johnson JM, Johnson AL. Cranial cruciate ligament rupture. Pathogenesis, diagnosis, and postoperative rehabilitation. Vet Clin North Am Small Anim Pract 1993; 23: 717-33.
7 Johnston SA. Osteoarthritis: joint anatomy, physiology and pathobiology. Vet Clin North Am Small Anim Pract 1997; 27: 699-724.
8 Loneux P, Balligand M. L'osteoarthrose chez le chien. I. Pathophysiologie et diagnostic. Ann Med Vet 1999; 143: 153-60.
9 Attur MG, Dave M, Akamatsu M. et al. Osteoarthritis or osteoarthrosis: the definition of inflammation becomes a semantic issue in the genomic era of molecular medicine. Osteoarthritis Cartilage 2002; 10: 1-4.
10 Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arth Rheum 2001; 44: 1237-47.
11 Hegemann N, Wondimu A, Kohn B. et al. Cytokine profile in canine immune-mediated polyarthritis and osteoarthritis. Vet Comp Orthop Traumatol 2005; 18: 67-72.
12 Conzemius MG, Evans RB, Besancon MF. et al. Effect of surgical technique on limb function after surgery for rupture of the cranial cruciate ligament in dogs. J Am Vet Med Assoc 2005; 226: 232-6.
13 Lazar TP, Berry CR, deHaan JJ. et al. Long-term radiographic comparison of tibial plateau leveling osteotomy versus extracapsular stabilization for cranial cruciate ligament rupture in the dog. Vet Surg 2005; 34: 133-41.
14 Aragon CL, Budsberg SC. Applications of evidence-based medicine: cranial cruciate ligament injury repair in the dog. Vet Surg 2005; 34: 93-8.
15 Innes JF, Barr AR, Sharif M. Efficacy of oral calcium pentosan polysulphate for the treatment of osteoarthritis of the canine stifle joint secondary to cranial cruciate ligament deficiency. Vet Ree 2000; 146: 433-7.
16 Henrotin Y, Sanchez C, Balligand M. Pharmaceutical and nutraceutical management of canine osteoarthritis: Present and future perspectives. Vet J 2005; 170: 113-23.
17 Beale BS. Use of nulraceuticals and chondro-protectants in osteoarthritic dogs and cats. Vet Clin North Am Small Anim Pract 2004; 34: 271-89.
18 Wang Y, Prentice LF, Vitetta L. et al. The effect of nutritional supplements on osteoarthritis. Altern Med Rev 2004; 9: 275-96.
19 Neil KM, Caron JP, Orth MW. The role of glucosamine and chondroitin sulphate in treatment for and prevention of osteoarthritis in animals. J Am Vet Med Assoc 2005; 226: 1079-88.
20 Marcolongo R, Fioravanti A. Terapia di fondo. In: L'artrosi Marcolongo R. (ed) Milano: Modern srl; 1996: 379-87.
21 Comalada M, Camuesco D, Sierra S. et al. In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway. Eur J Immunol 2005; 35: 584-92.
22 Ende C, Gebhardt R. Inhibition of matrix metallo-proteinase-2 and -9 activities by selected flavonoids. Planta Med 2004; 70: 1006-8.
23 Firuzi ø, Lacanna A, Petrucci R. et al. Evaluation of the antioxidant activity of flavonoids by “ferric reducing antioxidant power” assay and cyclic voltammetry. Biochim Biophys Acta 2005; 1721: 174-84.
24 Fabris M, Dalle Carbonare M, Leon A. et al. Quercetin protects canine articular chondrocytes from oxidative damage. Proceedings 1st World Orthopaedic Veterinary Congress ESVOT-VOS. Munich: September 5-8 2002. p. 69.
25 Teixeira S. Bioflavonoids: proanthocyanidins and quercetin and their potential roles in treating musculoskeletal conditions. J Orthop Sports Phys Ther 2002; 32: 357-63.
26 Fox DB, Cook JL. Synovial fluid markers of osteoarthritis in dogs. J Am Vet Med Assoc 2001; 219: 756-61.
27 Pelczer I. High-resolution NMR for metabomics. Curr Opin Drug Discov Devel 2005; 8: 127-33.
28 Dufiy JM, Grimshaw J, Guthrie DJ. et al. lH-nuclear magnetic resonance studies of human synovial fluid in arthritic disease states as an aid to confirming metabolic activity in the synovial cavity. Clin Sci 1993; 85: 343-51.
29 McKeag D, Smith BW, Edminster R. et al. Estimating the severity of osteoarthritis with magnetic resonance spectroscopy. Sem Arth Rheum 1992; 21: 227-38.
30 Meshitsuka S, Yamazaki E, Inoue M. et al. Nuclear magnetic resonance studies of synovial fluids from patients with rheumatoid arthritis and osteoarthritis. Clin Chim Acta 1999; 281: 163-7.
31 Damyanovich AZ, Staples JR, Chan AD. et al. Comparative study of normal and osteoarthritic canine synovial fluid using 500 MHz lHmagnetic resonance spectroscopy. J Orthop Res 1999; 17: 223-31.
32 Damyanovich AZ, Staples JR, Marshall KW. 1H NMR investigation of changes in the metabolic profile of synovial fluid in bilateral canine osteoarthritis with unilateral joint denervation. Osteoarthritis Cartilage 1999; 7: 165-72.
33 Denny HR, Barr ARS. An evaluation of two “over the top” techniques for anterior cruciate ligament replacement in the dog. J Small Anim Pract 1984; 25: 759-69.
34 Denny HR, Barr ARS. A further evaluation of the “over the top” technique for anterior cruciate ligament replacement in the dog. J Small Anim Pract 1987; 28: 681-6.
35 Pouchert CJ, Behnke J. The Aldrich Library of 13C and 1H FT-NMR Spectra Ist ed. Aldrich Chemical Company Inc; (ed) Milwaukee: 1993
36 Hull WE. Measurement of absolute metabolite concentrations in biological samples. Broker Report 1987; 2: 15-8.
37 Hayashi K, Manley PA, Muir P. Cranial cruciate ligament pathophysiology in dogs with cruciate disease: a review. J Am Anim Hosp Assoc 2004; 40: 385-90.
38 Moore KW, Read RA. Rupture of the cranial cruciate ligament in dogs.-Part I. Compend Cantin Educ 1996; 18: 223-33.
39 Johnson KA, Hülse DA, Hart RC. et al. Effects of an orally administered mixture of chondroitin sulphate, glucosamine hydrochloride and manganese ascorbate on synovial fluid chondroitin sulphate 3B3 and 7D4 epitope in a canine cruciate ligament transection model of osteoarthritis. Osteoarthritis Cartilage 2001; 9: 14-21.
40 Trumble TN, Billinghurst RC, Mcllwraith CW. Correlation of prostaglandin E2 concentrations in synovial fluid with ground reaction forces and clinical variables for pain or inflammation in dogs with osteoarthritis induced by transection of the cranial cruciate ligament. Am J Vet Res 2004; 65: 1269-75.
41 Grootveld M, Henderson DB, Farrell A. et al. Oxidative damage to hyaluronate and glucose in synovial fluid during exercise of the inflamed rheumatoid joint: detection of abnormal low molecular mass metabolites by proton-NMR spectroscopy. Biochem J 1991; 273: 459-67.
42 Brandt KD, Braunstein EM, Visco DM. et al. Anterior (cranial) cruciate ligament transection in the dog: a bona fide model of osteoarthritis, not merely of cartilage injury and repair. J Rheumatol 1991; 18: 436-46.
43 Innes JF, Sharif M, Barr AR. Changes in concentrations of biochemical markers of osteoarthritis following surgical repair of ruptured cranial cruciate ligaments in dogs. Am J Vet Res 1999; 60: 1164-8.
44 Johnson KA, Hay CW, Chu Q. et al. Cartilage-derived biomarkers of osteoarthritis in synovial fluid of dogs with naturally acquired rupture of the cranial cruciate ligament. Am J Vet Res 2002; 63: 775-81.
45 Johnson KA, Hart RC, Chu Q. et al. Concentrations of chondroitin sulphate epitopes 3B3 and 7D4 in synovial fluid after intra-articular and extracapsular reconstruction of the cranial cruciate ligament in dogs. Am J Vet Res 2001; 62: 581-7.
46 Lineberger JA, Allen DA, Wilson ER. et al. Comparison of radiographic arthritic changes associated with two variations of tibial plateau leveling osteotomy. Vet Comp Orthop Traumatol 2005; 1: 13-7.
47 Adebowale A, Du J, Liang Z. et al. The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulphate after single and multiple doses to beagle dogs. BiopharmDrug Dispos 2002; 23: 217-25.
48 Balant LP, Wermeille M, Griffiths LA. Metabolism and pharmacokinetics of hydroxyethylated rutosides in animals and man. Q Rev Drug Metab Drug Interact 1984; 5: 1-24.
49 Kudnig ST. Intra-articular replacement. Aust Vet J 2000; 78: 384-5.